Rubicon Research Merger Application Returned by Regional Director
Rubicon Research Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 5:11 pm
Rubicon Research Merger Application Returned by Regional Director The Regional Director, Western Region, returned Rubicon Research鈥檚 fast-track merger application with wholly-owned subsidiary KIA Health Tech Pvt Ltd via an order received on 13th Nov'26. The rejection occurred because shareholder approval reached 88.65% (versus the required 90% total) and unsecured creditor approval stood at 71.83% by value (versus the required 90%). The company is evaluating options, including filing through the regular NCLT route. Rubicon expects no material operational impact, as this is an internal restructuring and KIA Health Tech currently has no operations.
Original exchange filing (PDF)
More announcements from Rubicon Research Ltd
- Transcript of Earnings Call -Q2 - FY 2026-27 路 12 Nov 2026
- Audio Recording of Earnings confrence call for the Quarter ended 30th September, 2026 路 06 Nov 2026
- Monitoring Agency Report - Q2 ended September 2026 路 05 Nov 2026
- Investor Presentation for Q2 2026-27 路 05 Nov 2026
- Rubicon Research Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting held on November 5, 2026 路 05 Nov 2026
- Grant of Stock Options under Rubicon Research LImited Stock Option Plan 2026 路 05 Nov 2026
- Outcome of USFDA Inspection of Rubicon Research Ltd Manufactiring Facility at Ambernath, India 路 30 Oct 2026
